Dafna D Gladman

Dafna D Gladman, MD, FRCPC

Senior Scientist, Krembil Research Institute (Krembil)
Keywords: psoriatic arthritis, systemic lupus erythematosus (SLE), rheumatoid arthritis
Prognosis, genetic and theraupeutic studies in the rheumatic diseases particularly:
  • Psoriatic arthritis
  • Systemic lupus erythematosus
  • Rheumatoid arthritis

Related Links

Associated Program(s)
International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials.
Ann Rheum Dis. 2016 Sep 9;
Orbai AM, de Wit M, Mease P, Shea JA, Gossec L, Leung YY, Tillett W, Elmamoun M, Callis Duffin K, Campbell W, Christensen R, Coates L, Dures E, Eder L, FitzGerald O, Gladman D, Goel N, Grieb SD, Hewlett S, Hoejgaard P, Kalyoncu U, Lindsay C, McHugh N,...
Dr. Tselios, et al reply.
J Rheumatol. 2016 Sep;43(9):1767
Tselios K, Gladman DD, Su J, Urowitz MB
The Association of HLA-class I Genes and the Extent of Atherosclerotic Plaques in Patients with Psoriatic Disease.
J Rheumatol. 2016 Sep 1;
Eder L, Abji F, Rosen CF, Chandran V, Cook RJ, Gladman DD
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period...
Ann Rheum Dis. 2016 Aug 23;
Mease PJ, van der Heijde D, Ritchlin CT, Okada M, Cuchacovich RS, Shuler CL, Lin CY, Braun DK, Lee CH, Gladman DD, SPIRIT-P1 Study Group
Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus.
Lupus. 2016 Aug 13;
Cramarossa G, Urowitz MB, Su J, Gladman D, Touma Z
Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus.
J Clin Rheumatol. 2016 Aug;22(5):287-8
Tselios K, Gladman DD, Harvey P, Mak S, Chantal M, Butany J, Urowitz MB
Attainment of Minimal Disease Activity Using Methotrexate in Psoriatic Arthritis.
J Rheumatol. 2016 Jul 15;
Sheane BJ, Thavaneswaran A, Gladman DD, Chandran V
C-X-C Motif Chemokine 10 is a Possible Biomarker for the Development of Psoriatic Arthritis among Patients with Psoriasis.
Arthritis Rheumatol. 2016 Jul 7;
Abji F, Pollock RA, Liang K, Chandran V, Gladman DD
Prevalence and risk factors of low bone mineral density in psoriatic arthritis: A systematic review.
Semin Arthritis Rheum. 2016 May 25;
Chandran S, Aldei A, Johnson SR, Cheung AM, Salonen D, Gladman DD
Disease outcomes in corticosteroid-naïve patients with systemic lupus erythematosus.
Arthritis Care Res (Hoboken). 2016 May 23;
Sheane BJ, Gladman DD, Su J, Urowitz MB

Pages


 
Senior Scientist, Krembil Research Institute (Krembil)

Deputy Director, Centre for Prognosis Studies in the Rheumatic Diseases (part of the UHN Arthritis and Autoimmunity Research Centre)
Co-Director, Lupus Clinic, Toronto Western Hospital (TWH)
Director, Psoriatic Arthritis Program, TWH